Open-Label Extension to Evaluate the Safety of Hydrocodone Bitartrate Extended-Release Tablets

Study Title
Open-Label, Extension Study to Evaluate the Safety of Hydrocodone Bitartrate Extended-Release Tablets
Teva Identifier
C33237/3104
ClinicalTrials.gov Identifier
NCT01922739
Study Status
Completed
Trial Condition(s)
Low Back Pain
Interventions
Drug: Hydrocodone ER | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
18 Years to 80 Years
Trial Duration
07/01/2013 - 08/01/2014
Phase
Phase 3

Study Type

Interventional